Related references
Note: Only part of the references are listed.Prepandemic viral community-acquired pneumonia: Diagnostic sensitivity and specificity of nasopharyngeal swabs and performance of clinical severity scores
Judith Berastegui-Cabrera et al.
JOURNAL OF MEDICAL VIROLOGY (2023)
Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19
Evdoxia Kyriazopoulou et al.
SCIENTIFIC REPORTS (2023)
Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients
Raquel Carbonell et al.
JOURNAL OF INFECTION (2022)
Lower serum alpha 1 antitrypsin levels in patients with severe COVID-19 compared with patients hospitalized due to non-COVID-19 pneumonia
Barak Pertzov et al.
INFECTIOUS DISEASES (2022)
The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures
Naomi J. Gadsby et al.
CLINICAL MICROBIOLOGY REVIEWS (2022)
A Potential Role of Interleukin 10 in COVID-19 Pathogenesis
Ligong Lu et al.
TRENDS IN IMMUNOLOGY (2021)
Is procalcitonin a reliable marker of bacterial community-acquired pneumonia in adults admitted to the emergency department during SARS-CoV-2 pandemic?
Stefano Malinverni et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2021)
Pneumonia
Antoni Torres et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Community-acquired pneumonia
Stefano Aliberti et al.
LANCET (2021)
Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis
Ishan S. Kamat et al.
CLINICAL INFECTIOUS DISEASES (2020)
Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in
Fang Liu et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Predicting Disease Severity and Outcome in COVID-19 Patients
Youley Tjendra et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline
Mathias W. Pletz et al.
CHEST (2020)
Monocytes and Macrophages in Alpha-I Antitrypsin Deficiency
Kylie B. R. Belchamber et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Etiology of community-acquired pneumonia in adults: a systematic review
Saeed Shoar et al.
PNEUMONIA (2020)
The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
Remi Porte et al.
FRONTIERS IN IMMUNOLOGY (2019)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
FilmArray respiratory panel assay: An effective method for detecting viral and atypical bacterial pathogens in bronchoscopy specimens
Kerstin Locher et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
C-reactive protein: guiding antibiotic prescribing decisions at the point of care
Jochen W. L. Cals et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2018)
Low procalcitonin, community acquired pneumonia, and antibiotic therapy
Ishan S. Kamat et al.
LANCET INFECTIOUS DISEASES (2018)
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
Philipp Schuetz et al.
LANCET INFECTIOUS DISEASES (2018)
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection
D. T. Huang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics
Iram Yunus et al.
PLOS ONE (2018)
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
Manuela Carugati et al.
ERJ OPEN RESEARCH (2018)
Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe
Y. Alimi et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2017)
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
Wesley H. Self et al.
CLINICAL INFECTIOUS DISEASES (2017)
Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia
Clarissa Valim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Community-Acquired Pneumonia Requiring Hospitalization among US Adults
S. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune-modulating effects of alpha-1 antitrypsin
Mario R. Ehlers
BIOLOGICAL CHEMISTRY (2014)
Evaluation of the BioFire FilmArray Respiratory Panel and the GenMark eSensor Respiratory Viral Panel on Lower Respiratory Tract Specimens
Phyllis Ruggiero et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia
Elisabeth G. W. Huijskens et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Community-Acquired Pneumonia
Daniel M. Musher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cytokine markers as predictors of type of respiratory infection in patients during the influenza season
John Patrick Haran et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2013)
The discovery of α1-antitrypsin and its rote in health and disease
Sabina M. Janciauskiene et al.
RESPIRATORY MEDICINE (2011)
Sputum colour for diagnosis of a bacterial infection in patients with acute cough
Attila Altiner et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2009)
Relaxing the rule of ten events per variable in logistic and Cox regression
Eric Vittinghoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia a Randomized trial
Miriam Christ-Crain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Share Paper
